| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |